Skip to main content
. 2020 Jul 13;21(14):4951. doi: 10.3390/ijms21144951

Figure 1.

Figure 1

Overview of the current treatment approach in MTC. In this figure, we illustrate several drugs targeting the main molecular pathways involved in MTC tumorigenesis (MAPK and PI3K/AKT/mTOR), with special focus on the latest advances in RET inhibition.